American Journal of Epidemiology Vol. 123, No. 5: 840-845
Copyright © 1986 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
THE EPIDEMIOLOGY OF SARCOIDOSIS IN ROCHESTER, MINNESOTA: A POPULATION-BASED STUDY OF INCIDENCE AND SURVIVAL1
2Colorado Occupational Health Associates Boulder, CO
3Orthopedic surgery resident, Mayo Clinic Rochester, MN
Reprint requests to Dr. Leonard T. Kurland
Using the unique data resources of the Rochester Epidemiology Project, a community-based study of clinically diagnosed sarcoidosis was conducted. In this population-based study, the 75 Rochester, Minnesota, residents with sarcoidosis initially diagnosed between 1946 and 1975 (incidence cohort) were followed through their comprehensive medical records in the community to January 1, 1982. The age- and sex-adjusted incidence of sarcoidosis was 6.1 per 100,000 person-years. The age-adjusted incidence of sarcoidosis was similar in males (5.9) and females (6.3), with a peak incidence in males 30 to 39 years old (18.7) and in females 40 to 49 years old (15.6). A secular increase in sarcoidosis incidence was noted in the period 1946–1975 for females, with a marked increase in the number and percentage of biopsy-documented cases. Seasonal variation in sarcoidosis incidence was minimal, with a seasonal peak of 31% of the Rochester cases being diagnosed during the spring (March-May). Survival, compared with that of the North Central United States, was unimpaired in this sarcoidosis incidence cohort.
follow-up studies; sarcoidosis
1From the Department of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Ji, X. Shu, X. Li, K. Sundquist, J. Sundquist, and K. Hemminki Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden Ann. Onc., June 1, 2009; 20(6): 1121 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shah, G.H. Roberson, and J.K. Cure Correlation of MR Imaging Findings and Clinical Manifestations in Neurosarcoidosis AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 953 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Morimoto, A. Azuma, S. Abe, J. Usuki, S. Kudoh, K. Sugisaki, M. Oritsu, and T. Nukiwa Epidemiology of sarcoidosis in Japan Eur. Respir. J., February 1, 2008; 31(2): 372 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W Dubrey, A. Bell, and T. K Mittal Sarcoid heart disease Postgrad. Med. J., October 1, 2007; 83(984): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hill, A. Papafili, H. Booth, P. Lawson, M. Hubner, H. Beynon, C. Read, G. Lindahl, R. P. Marshall, R. J. McAnulty, et al. Functional Prostaglandin-Endoperoxide Synthase 2 Polymorphism Predicts Poor Outcome in Sarcoidosis Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 915 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Newman, C. S. Rose, E. A. Bresnitz, M. D. Rossman, J. Barnard, M. Frederick, M. L. Terrin, S. E. Weinberger, D. R. Moller, G. McLennan, et al. A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1324 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Visser, K Vos, E Zanelli, W Verduyn, G M T. Schreuder, I Speyer, F C Breedveld, and J M W Hazes Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors Ann Rheum Dis, June 1, 2002; 61(6): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Reich Mortality of Intrathoracic Sarcoidosis in Referral vs Population-Based Settings : Influence of Stage, Ethnicity, and Corticosteroid Therapy Chest, January 1, 2002; 121(1): 32 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. RYBICKI, M. C. IANNUZZI, M. M. FREDERICK, B. W. THOMPSON, M. D. ROSSMAN, E. A. BRESNITZ, M. L. TERRIN, D. R. MOLLER, J. BARNARD, R. P. BAUGHMAN, et al. Familial Aggregation of Sarcoidosis . A Case-Control Etiologic Study of Sarcoidosis (ACCESS) Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. BAUGHMAN, A. S. TEIRSTEIN, M. A. JUDSON, M. D. ROSSMAN, H. YEAGER JR., E. A. BRESNITZ, L. DEPALO, G. HUNNINGHAKE, M. C. IANNUZZI, C. J. JOHNS, et al. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1885 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hunninghake Statement on Sarcoidosis Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 736 - 755. [Full Text]
|
|
|
|
 |
|
 L. S. Newman, C. S. Rose, and L. A. Maier Sarcoidosis N. Engl. J. Med., April 24, 1997; 336(17): 1224 - 1234. [Full Text] [PDF]
|
|